August 18
2:00 – 3:00 p.m.
Auditorium between building 2 and 3
Don’t miss this opportunity to hear from Dr. Pascal Steiner, PhD, whose extensive experience spans academia and industry, including EPFL, Harvard Medical School, Genentech, and Nestlé Health Science. This seminar will explore the intersection of neuroscience, nutrition, and health, highlighting innovative research and solutions to promote healthy longevity.
Dr. Steiner’s journey has been driven by a commitment to translating scientific discovery into real-world health impacts. His work focuses on enhancing healthspan through innovative clinical programs targeting brain health and metabolism.
About the speaker
Pascal received his BSc from the University of Lausanne, a PhD in Neuroscience from the Swiss Federal Institute of Technology in 2004, and completed a postdoctoral fellowship at Harvard Medical School, Boston, in 2008. He then served as Director of Operations at Tilocor International, a biotech consortium, where he supervised the transfer process of drug candidate products from research towards clinical development. From 2010 to 2015, Pascal worked in the Neuroscience Department at Genentech in South San Francisco, leading an interdisciplinary team to discover and develop new drug targets in neurological diseases, including amyotrophic lateral sclerosis, Alzheimer’s disease, and pain. In 2015, Pascal joined the Nestlé Institute of Health Science in Lausanne, Switzerland, where he founded and led the Brain Health Department, shaping Nestlé’s neuroscience research agenda to support innovation across multiple consumer health brands. In 2020, Pascal joined Purina R&D Center in St. Louis as the senior director of the Nestle Purina Nutrition Science Team. There, he led integration of multi-omics and AI-based innovation platforms, built cross-functional bridges between R&D and business units, and established strategic alliances to accelerate the translation of pet health research into human health solutions. In 2025, Pascal joined Nestlé Health Science as the global head of medical nutrition and he is leading clinical programs targeting brain health, metabolism and longevity, including the company’s largest clinical trial in Mild Cognitive Impairment.